Skip to main content
Premium Trial:

Request an Annual Quote

Cepheid Gets FDA Clearance for Xpert Norovirus Assay

NEW YORK (GenomeWeb) — Cepheid said today that it has received US Food and Drug Administration clearance to market Xpert Norovirus, a qualitative in vitro diagnostic test for the identification and differentiation of norovirus genogroup I (GI) and genogroup II (GII).

Cepheid also said that Xpert Norovirus, as well as Xpert Flu/RSV — which was cleared by FDA last week — have been categorized as moderate complexity tests under CLIA guidelines. All Xpert tests run on Cepheid's GeneXpert system.

Norovirus is highly contagious and is the most common cause of viral gastroenteritis worldwide. Noroviruses can be transmitted from an infected person, contaminated food or water, or by touching contaminated surfaces. According to the US Centers for Disease Control and Prevention, it is the leading cause of disease outbreaks from contaminated food, causes an estimated 21 million illnesses, and contributes to between 56,000 and 71,000 hospitalizations in the US annually.

"Xpert Norovirus enables on-demand molecular detection and differentiation of the GI and GII norovirus genogroups, which together account for the vast majority of human infections," David Persing, chief medical and technology officer at Cepheid, said in a statement. "Norovirus outbreaks require immediate implementation of targeted infection control procedures, and this new test gives clinicians accurate results in as little as one hour."

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.